//
The Amgen Safety Net Foundation (ASNF) is a nonprofit patient assistance program that provides free access to certain Amgen medications for eligible patients who are uninsured or underinsured and demonstrate financial need. The program covers a wide range of Amgen therapies and is designed to ensure that patients who might otherwise go without important medicines due to financial barriers can access their treatment at no cost.
Amgen Safety Net Foundation is a private corporation based in THOUSAND OAKS, CA. The foundation received its IRS ruling in 2003. The principal officer is % Jim Loper. It holds total assets of $723.7M. Annual income is reported at $2.7B. THE PRIMARY FUNCTION OF AMGEN SAFETY NET FOUNDATION ("ASNF") IS TO PROVIDE POOR, INDIGENT AND FINANCIALLY DISTRESSED PATIENTS WITH ACCESS TO CERTAIN PRESCRIPTION DRUG THERAPIES THAT THEY COULD NOT OTHERWISE AFFORD. THE PRESCRIPTION DRUGS THAT ASNF DISTRIBUTES ARE PRODUCTS PRODUCED BY AMGEN INC. AND ITS AFFILIATES. AMGEN INC. AND ITS AFFILIATES CONTRIBUTE ALL DRUG PRODUCTS TO ASNF AT NO COST. (AMGEN INC. IS A GLOBAL BIOTECHNOLOGY COMPANY THAT DISCOVERS, DEVELOPS, MANUFACTURES AND MARKETS HUMAN THERAPEUTICS BASED ON ADVANCES IN CELLULAR AND MOLECULAR BIOLOGY.) IN PARTICULAR ASNF DISTRIBUTES ARANESP, EPOGEN, NEULASTA, N-PLATE, NEUPOGEN, PROLIA, XGEVA, SENSIPAR, VECTIBIX, CORLANOR, REPATHA, BLINCYTO, KYPROLIS, IMLYGIC, ENBREL, PARSABIV, AIMOVIG, EVENITY, KANJINTI, MVASI, AVSOLA, RIABNI, LUMAKRAS, & OTEZLA. According to available records, Amgen Safety Net Foundation has made 1 grants totaling $10K, with a median grant of $10K. Grant recipients are concentrated in Kansas. Contributions to this foundation are tax-deductible.
THE PRIMARY FUNCTION OF AMGEN SAFETY NET FOUNDATION ("ASNF") IS TO PROVIDE POOR, INDIGENT AND FINANCIALLY DISTRESSED PATIENTS WITH ACCESS TO CERTAIN PRESCRIPTION DRUG THERAPIES THAT THEY COULD NOT OTHERWISE AFFORD. THE PRESCRIPTION DRUGS THAT ASNF DISTRIBUTES ARE PRODUCTS PRODUCED BY AMGEN INC. AND ITS AFFILIATES. AMGEN INC. AND ITS AFFILIATES CONTRIBUTE ALL PHARMACEUTICAL PRODUCTS TO ASNF AT NO COST. (AMGEN INC. IS A GLOBAL BIOTECHNOLOGY COMPANY THAT DISCOVERS, DEVELOPS, MANUFACTURES AND MARKETS HUMAN THERAPEUTICS BASED ON ADVANCES IN CELLULAR AND MOLECULAR BIOLOGY.) IN PARTICULAR, ASNF DISTRIBUTES ARANESP, EPOGEN, NEULASTA, N-PLATE, NEUPOGEN, PROLIA, XGEVA, SENSIPAR, VECTIBIX, CORLANOR, REPATHA, BLINCYTO, KYPROLIS, IMLYGIC, ENBREL, PARSABIV, AIMOVIG, EVENITY, KANJINTI, MVASI, AVSOLA, RIABNI, LUMAKRAS, OTEZLA, TEZSPIRE AND AMJEVITA.
Expenses: $2.6B
THE PRIMARY FUNCTION OF AMGEN SAFETY NET FOUNDATION ("ASNF") IS TO PROVIDE POOR, INDIGENT AND FINANCIALLY DISTRESSED PATIENTS WITH ACCESS TO CERTAIN PRESCRIPTION DRUG THERAPIES THAT THEY COULD NOT OTHERWISE AFFORD. THE PRESCRIPTION DRUGS THAT ASNF DISTRIBUTES ARE PRODUCTS PRODUCED BY AMGEN INC. AND ITS AFFILIATES. AMGEN INC. AND ITS AFFILIATES CONTRIBUTE ALL DRUG PRODUCTS TO ASNF AT NO COST. (AMGEN INC. IS A GLOBAL BIOTECHNOLOGY COMPANY THAT DISCOVERS, DEVELOPS, MANUFACTURES AND MARKETS HUMAN THERAPEUTICS BASED ON ADVANCES IN CELLULAR AND MOLECULAR BIOLOGY.) IN PARTICULAR ASNF DISTRIBUTES ARANESP, EPOGEN, NEULASTA, N-PLATE, NEUPOGEN, PROLIA, XGEVA, SENSIPAR, VECTIBIX, CORLANOR, REPATHA, BLINCYTO, KYPROLIS, IMLYGIC, ENBREL, PARSABIV, AIMOVIG, EVENITY, KANJINTI, MVASI, AVSOLA, RIABNI, LUMAKRAS, & OTEZLA. Based on available records, the foundation has funded 1 grants. Its grantmaking reaches organizations primarily in KS.
Amgen Safety Net Foundation has distributed a total of $10K across 1 grants. The median grant size is $10K, with an average of $10K. Individual grants have ranged from $10K to $10K.
IN GENERAL, APPLICANTS MUST: 1) BE A RESIDENT OF THE UNITED STATES. 2) DEMONSTRATE FINANCIAL NEED, WHICH IS BASED ON THE PATIENT'S ANNUAL HOUSEHOLD INCOME AS A MULTIPLE OF THE FEDERAL POVERTY LEVEL (FPL) AND FAMILY SIZE. 3) PROOF OF INCOME MAY BE REQUIRED. 4) IN ADDITION TO SATISFYING THE GENERAL ELIGIBILITY CRITERIA, AN APPLICANT MUST MEET ADDITIONAL CRITERIA WHICH ARE BASED ON INSURANCE COVERAGE STATUS.
Amgen Safety Net Foundation is headquartered in THOUSAND OAKS, CA.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| W Blair Fields | PRESIDENT | $0 | $0 | $0 |
| Emily Razaqi | DIRECTOR | $0 | $0 | $0 |
| Shannon Kilbane | DIRECTOR | $0 | $0 | $0 |
| Kate Tansey Chevlen | DIRECTOR | $0 | $0 | $0 |
| Casper Partovi | DIRECTOR | $0 | $0 | $0 |
Total Giving
$2.6B
Total Assets
$542.3M
Fair Market Value
$542.3M
Net Worth
$539.5M
Grants Paid
$0
Contributions
$2.4B
Net Investment Income
$2M
Distribution Amount
$0
Total Grants
1
Total Giving
$10K
Average Grant
$10K
Median Grant
$10K
Unique Recipients
1
Most Common Grant
$10K
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Heart To Heart International2,000 PERSONAL HYGIENE KITS | Lenexa, KS | $10K | 2022 |
| Matt Busch |
| DIRECTOR |
| $0 |
| $0 |
| $0 |
| Alan Jamijian | TREASURER | $0 | $0 | $0 |
| Jean-Pierre Llanos Ackert | DIRECTOR | $0 | $0 | $0 |
| Dennis Yai | SECRETARY | $0 | $0 | $0 |
| J Page Buchanan | VICE PRESIDE | $0 | $0 | $0 |
| Andrea Robinson | ASSISTANT SE | $0 | $0 | $0 |
| Paul Mowad | DIRECTOR | $0 | $0 | $0 |
| Micki Unkrich | DIRECTOR | $0 | $0 | $0 |
| Lisa Gruber | DIRECTOR | $0 | $0 | $0 |
| Emily Mason | DIRECTOR | $0 | $0 | $0 |
| 2018 | 990PF | View |
| 2017 | 990PF | View |
| 2015 | 990PF | View |
© 2026 Granted AI